The DOI matches its Crossref record.
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 44
- Kubinyi, 1995, Strategies and recent technologies in drug discovery, Pharmazie, 50, 647
- Moos, 1993, Recent Advances in the Generation of Molecular Diversity, Annu. Rep. Med. Chem., 28, 315, 10.1016/S0065-7743(08)60903-3 · DOI
- Patel, 1996, Applications of small-molecule combinatorial chemistry to drug discovery, Drug Discov. Today, 1, 134, 10.1016/1359-6446(96)89062-3 · DOI
- Baum, 1994, Combinatorial approaches provide fresh leads for medicinal chemistry, Chem. Eng. News February, 7, 20, 10.1021/cen-v072n006.p020 · DOI
- Chow, 1995, Using backpropagation networks for the estimation of aqueous activity coefficients of aromatic compounds, J. Chem. Inf. Comput. Sci., 35, 723, 10.1021/ci00026a009 · DOI
- Andrews, 1984, Functional group contributions to drug-receptor interactions, J. Med. Chem., 27, 1648, 10.1021/jm00378a021 · DOI · Paper page
- Navia, 1996, Design principles for orally bioavailable drugs, Drug. Dev. Today, 1, 179, 10.1016/1359-6446(96)10020-9 · DOI
- Pardridge, 1995, Transport of small molecules through the blood-brain barrier: biology and methodology, Adv. Drug Deliv. Rev., 15, 5, 10.1016/0169-409X(95)00003-P · DOI · Paper page
- Cohen, 1972, Diffusion of small non-electrolytes across liposome membranes, Nature, 236, 173, 10.1038/236173a0 · DOI
- Testa, 1996, Lipophilicity in molecular modelling, Pharm. Res., 13, 335, 10.1023/A:1016024005429 · DOI
- Moriguchi, 1992, Simple method of calculating octanol/water partition coefficient, Chem. Pharm. Bull., 40, 127, 10.1248/cpb.40.127 · DOI · Paper page
- Moriguchi, 1994, Comparison of log P values for drugs calculated by several methods, Chem. Pharm. Bull., 42, 976, 10.1248/cpb.42.976 · DOI · Paper page
- Leo, 1995, Critique of recent comparison of log P calculation methods, Chem. Pharm. Bull., 43, 512, 10.1248/cpb.43.512 · DOI
- Abraham, 1994, Hydrogen bonding. 32. An analysis of water-octanol and water-alkane partitioning and the delta log P parameter of Seiler, J. Pharm. Sci., 83, 1085, 10.1002/jps.2600830806 · DOI · Paper page
- Paterson, 1994, A non-aqueous partitioning system for predicting the oral absorption potential of peptides, Quant. Struct.-Act. Relatsh., 13, 4, 10.1002/qsar.19940130103 · DOI
- Hillgren, 1995, In vitro systems for studying intestinal drug absorption, Med. Res. Rev., 15, 83, 10.1002/med.2610150202 · DOI
- Abraham, 1993, Hydrogen bonding. 31. Construction of a scale of solute effective or summation hydrogen-bond basicity, J. Phys. Org. Chem., 6, 660, 10.1002/poc.610061204 · DOI · Paper page
- Raevsky, 1992, Complete thermodynamic description of Hbonding in the framework of multiplicative approach, Quant. Struct.-Act. Relatsh., 11, 49, 10.1002/qsar.19920110109 · DOI
- Raevsky, 1995, HBond contribution to octanol-water partition coefficients of polar compounds, Quant. Struct.-Act. Relatsh., 14, 433, 10.1002/qsar.19950140504 · DOI
- Bodor, 1991, Neural network studies. 1. Estimation of the aqueous solubility of organic compounds, J. Am. Chem. Soc., 113, 9480, 10.1021/ja00025a009 · DOI
- Gavezzotti, 1994, Are crystal structures predictable?, Acc. Chem. Res., 27, 309, 10.1021/ar00046a004 · DOI · Paper page
- Abraham, 1993, Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processes, Chem. Soc. Rev., 22, 73, 10.1039/cs9932200073 · DOI · Paper page
- Abraham, 1987, The use of characteristic volumes to measure cavity terms in reversed phase liquid chromatography, Chromatographia, 23, 243, 10.1007/BF02311772 · DOI · Paper page
- Taft, 1985, The molecular properties governing solubilities of organic nonelectrolytes in water, Nature, 315, 384, 10.1038/313384a0 · DOI
- Kamlet, 1993, Linear solvation energy relationships: an improved equation for correlation and prediction of aqueous solubilities of aromatic solutes including polycyclic aromatic hydrocarbons and polychlorinated biphenyls, Prog. Phys. Org. Chem., 19, 295, 10.1002/9780470171981.ch5 · DOI
- Abraham, 1994, Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain, J. Pharm. Sci., 83, 1257, 10.1002/jps.2600830915 · DOI · Paper page
- Brinck, 1993, Octanol/water partition coefficients expressed in terms of solute molecular surface areas and electrostatic potentials, J. Org. Chem., 58, 7070, 10.1021/jo00077a028 · DOI
- Murray, 1991, Correlations between the solvent hydrogen-bond-donating parameter α and the calculated molecular surface electrostatic potential, J. Org. Chem., 56, 6715, 10.1021/jo00023a045 · DOI
- Murray, 1991, Correlations between the solvent hydrogen bond acceptor parameter β and the calculated molecular electrostatic potential, J. Org. Chem., 56, 3734, 10.1021/jo00011a060 · DOI
- Famini, 1992, Using theoretical descriptors in quantitative structure activity relationships: some physicochemical properties, J. Phys. Org. Chem., 5, 395, 10.1002/poc.610050704 · DOI
- Headley, 1994, Analysis of solute/solvent interactions for the acidity of acetic acids by theoretical descriptors, J. Org. Chem., 59, 8040, 10.1021/jo00105a020 · DOI
- Ruelle, 1994, Prediction of carbazole solubility and its dependence upon the solvent nature, Int. J. Pharm., 104, 125, 10.1016/0378-5173(94)90187-2 · DOI
- Ruelle, 1991, A new predictive equation for the solubility of drugs based on the thermodynamics of mobile disorder, Pharm. Res., 8, 840, 10.1023/A:1015891126287 · DOI
- Ruelle, 1994, Solubility predictions for solid nitriles and tertiary amides based on the mobile order theory, Pharm. Res., 11, 201, 10.1023/A:1018990904867 · DOI
- Yalkowski, 1980, Solubility and partitioning 1: solubility of nonelectrolytes in water, J. Pharm. Sci., 69, 912, 10.1002/jps.2600690814 · DOI · Paper page
- Abramovitz, 1990, Estimation of aqueous solubility and melting point of PCB congeners, Chemosphere, 21, 1221, 10.1016/0045-6535(90)90142-G · DOI
- Yalkowski, 1993, Estimation of the solubility of complex organic compounds, Chemosphere, 26, 1239, 10.1016/0045-6535(93)90179-9 · DOI
- Leo, 1993, Calculating log Poct from structures, Chem. Rev., 93, 1281, 10.1021/cr00020a001 · DOI · Paper page
- Abramovitz, 1990, Melting point, boiling point, and symmetry, Pharm. Res., 7, 942, 10.1023/A:1015949907825 · DOI
- Dannenfelser, 1993, Molecular symmetry and related properties, SAR & QSAR Environ. Res., 1, 273, 10.1080/10629369308029892 · DOI
- Suzuki, 1991, Development of an automatic estimation system for both the partition coefficient and aqueous solubility, J. Comput. Aided Mol. Des., 5, 149, 10.1007/BF00129753 · DOI
- Myrdal, 1995, Aquafac 3: aqueous functional group activity coefficients; application to the estimation of aqueous solubility, Chemosphere, 30, 1619, 10.1016/0045-6535(95)00026-5 · DOI
- Bodor, 1992, A new method for the estimation of the aqueous solubility of organic compounds, J. Pharm. Sci., 81, 954, 10.1002/jps.2600810924 · DOI
- Nelson, 1994, Prediction of aqueous solubility of organic compounds, J. Chem. Int. Comput. Sci., 34, 601, 10.1021/ci00019a019 · DOI
Cited by
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman, C. U., & Mohan, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00299 · Cited by 2,654
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Pharmaceuticals as emerging contaminants and their removal from water. A review
Rivera-Utrilla, J., Sánchez-Polo, M., Ferro-García, M. Á., Prados-Joya, G., & Ocampo-Pérez, R. (2013) · Chemosphere · doi:10.1016/j.chemosphere.2013.07.059 · Cited by 1,486
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450
Virtual screening of chemical libraries
Shoichet, B. K. (2004) · Nature · doi:10.1038/nature03197 · Cited by 1,425
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173
The role of ligand efficiency metrics in drug discovery
Hopkins, A. L., Keserü, G. M., Leeson, P. D., Rees, D. C., & Reynolds, C. H. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4163 · Cited by 1,181
Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891
GuacaMol: Benchmarking Models for de Novo Molecular Design
Brown, N., Fiscato, M., Segler, M. H. S., & Vaucher, A. C. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00839 · Cited by 895
Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges
Vinogradov, A. A., Yin, Y., & Suga, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13178 · Cited by 848
Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins
Yang, N. J., & Hinner, M. J. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2272-7_3 · Cited by 826
Automated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.013 · Cited by 835
Inhibition of α-helix-mediated protein–protein interactions using designed molecules
Azzarito, V., Long, K., Murphy, N. S., & Wilson, A. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1568 · Cited by 727
Reymond, J.-L. (2015) · Accounts of Chemical Research · doi:10.1021/ar500432k · Cited by 720
Characteristics of Compounds that Cross the Blood-Brain Barrier
Banks, W. A. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-s1-s3 · Cited by 710
Charifson, P. S., Corkery, J. J., Murcko, M. A., & Walters, W. P. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990352k · Cited by 698
Deep learning for molecular design—a review of the state of the art
Elton, D. C., Boukouvalas, Z., Fuge, M. D., & Chung, P. W. (2019) · Molecular Systems Design & Engineering · doi:10.1039/c9me00039a · Cited by 683
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Diversity-oriented synthesis: Exploring the intersections between chemistry and biology
Tan, D. S. (2005) · Nature Chemical Biology · doi:10.1038/nchembio0705-74 · Cited by 605
Targeting lipophilic cations to mitochondria
Murphy, M. P. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.03.029 · Cited by 598
N-Methylation of Peptides: A New Perspective in Medicinal Chemistry
Chatterjee, J., Gilon, C., Hoffman, A., & Kessler, H. (2008) · Accounts of Chemical Research · doi:10.1021/ar8000603 · Cited by 577
Properties of FDA-approved small molecule protein kinase inhibitors
Roskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.006 · Cited by 554
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Dobson, P. D., & Kell, D. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2438 · Cited by 475
Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?
Ajay, Walters, W. P., & Murcko, M. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970666c · Cited by 484
Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
Churcher, I. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01272 · Cited by 491
Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
Wu, P., Nielsen, T. E., & Clausen, M. H. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.008 · Cited by 457
Tomás‐Barberán, F. A., González‐Sarrías, A., García‐Villalba, R., Núñez‐Sánchez, M. A., Selma, M. V., García‐Conesa, M. T., & Espín, J. C. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500901 · Cited by 465
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
Five computational developability guidelines for therapeutic antibody profiling
Raybould, M. I. J., Marks, C., Krawczyk, K., Taddese, B., Nowak, J., Lewis, A. P., Bujotzek, A., Shi, J., & Deane, C. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810576116 · Cited by 357
Therapies for rare diseases: therapeutic modalities, progress and challenges ahead
Tambuyzer, E., Vandendriessche, B., Austin, C. P., Brooks, P. J., Larsson, K., Miller Needleman, K. I., Valentine, J., Davies, K., Groft, S. C., Preti, R., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0049-9 · Cited by 357
Drug research: myths, hype and reality
Kubinyi, H. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1156 · Cited by 348
Stress Biomarkers in Biological Fluids and Their Point-of-Use Detection
Steckl, A. J., & Ray, P. (2018) · ACS Sensors · doi:10.1021/acssensors.8b00726 · Cited by 319
Utilizing graph machine learning within drug discovery and development
Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R., Roberts, C., Tang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab159 · Cited by 313
Virshup, A. M., Contreras-García, J., Wipf, P., Yang, W., & Beratan, D. N. (2013) · Journal of the American Chemical Society · doi:10.1021/ja401184g · Cited by 294
Rishton, G. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.007 · Cited by 276
Ye, S., Huang, Y., Müllendorff, K., Dong, L., Giedt, G., Meng, E. C., Cohen, F. E., Kuntz, I. D., Weisgraber, K. H., & Mahley, R. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508693102 · Cited by 275
Ursu, O., Rayan, A., Goldblum, A., & Oprea, T. I. (2011) · WIREs Computational Molecular Science · doi:10.1002/wcms.52 · Cited by 276
Squaramides as potent transmembrane anion transporters
Busschaert, N., Kirby, I. L., Young, S., Coles, S. J., Horton, P. N., Light, M. E., & Gale, P. A. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201200729 · Cited by 269
A Perspective on Multi-target Drugs for Alzheimer’s Disease
Benek, O., Korabecny, J., & Soukup, O. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.04.008 · Cited by 260
Letchford, K., Liggins, R., & Burt, H. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21037 · Cited by 254
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
Hartenfeller, M., Zettl, H., Walter, M., Rupp, M., Reisen, F., Proschak, E., Weggen, S., Stark, H., & Schneider, G. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002380 · Cited by 251
Martin, Y. C. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9303-2 · Cited by 237
Xiong, B., Wang, Y., Chen, Y., Xing, S., Liao, Q., Chen, Y., Li, Q., Li, W., & Sun, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00910 · Cited by 232
Artificial Intelligence for Drug Discovery: Are We There Yet?
Hasselgren, C., & Oprea, T. I. (2024) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-040323-040828 · Cited by 236
Thomas, N., Holm, R., Müllertz, A., & Rades, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.027 · Cited by 215
Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades
Göller, A. H., Kuhnke, L., Montanari, F., Bonin, A., Schneckener, S., ter Laak, A., Wichard, J., Lobell, M., & Hillisch, A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.001 · Cited by 215
Rodríguez-Rodríguez, C., Sánchez de Groot, N., Rimola, A., Álvarez-Larena, Á., Lloveras, V., Vidal-Gancedo, J., Ventura, S., Vendrell, J., Sodupe, M., & González-Duarte, P. (2009) · Journal of the American Chemical Society · doi:10.1021/ja806062g · Cited by 210
Solution Conformations Shed Light on PROTAC Cell Permeability
Atilaw, Y., Poongavanam, V., Svensson Nilsson, C., Nguyen, D., Giese, A., Meibom, D., Erdelyi, M., & Kihlberg, J. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00556 · Cited by 208
Holzer, P., Masuya, K., Furet, P., Kallen, J., Valat-Stachyra, T., Ferretti, S., Berghausen, J., Bouisset-Leonard, M., Buschmann, N., Pissot-Soldermann, C., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00810 · Cited by 203
Small Molecule Modulators of Copper-Induced Aβ Aggregation
Hindo, S. S., Mancino, A. M., Braymer, J. J., Liu, Y., Vivekanandan, S., Ramamoorthy, A., & Lim, M. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907045h · Cited by 203
Smith, A. J. T., Zhang, X., Leach, A. G., & Houk, K. N. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800498e · Cited by 193
Modeling the expansion of virtual screening libraries
Lyu, J., Irwin, J. J., & Shoichet, B. K. (2023) · Nature Chemical Biology · doi:10.1038/s41589-022-01234-w · Cited by 193
Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier
Banks, W. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.005 · Cited by 184
Prediction of intestinal absorption: comparative assessment of gastroplus™ and idea™
Parrott, N., & Lavé, T. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00132-x · Cited by 170
Chemo- and site-selective derivatizations of natural products enabling biological studies
Robles, O., & Romo, D. (2014) · Nat. Prod. Rep. · doi:10.1039/c3np70087a · Cited by 154
Rodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151
Sambanthamoorthy, K., Sloup, R. E., Parashar, V., Smith, J. M., Kim, E. E., Semmelhack, M. F., Neiditch, M. B., & Waters, C. M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01396-12 · Cited by 151
Applications of Human Pharmacokinetic Prediction in First-in-Human Dose Estimation
Zou, P., Yu, Y., Zheng, N., Yang, Y., Paholak, H. J., Yu, L. X., & Sun, D. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9332-y · Cited by 138
Buchwald, P. (2010) · IUBMB Life · doi:10.1002/iub.383 · Cited by 133
Design of iron chelators with therapeutic application
Zhou, T., Ma, Y., Kong, X., & Hider, R. C. (2012) · Dalton Transactions · doi:10.1039/c2dt12159j · Cited by 136
Bockus, A. T., Schwochert, J. A., Pye, C. R., Townsend, C. E., Sok, V., Bednarek, M. A., & Lokey, R. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00919 · Cited by 135
Fragment-Based Lead Discovery and Design
Joseph-McCarthy, D., Campbell, A. J., Kern, G., & Moustakas, D. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400731w · Cited by 129
Zhao, Z.-W., del Cueto, M., Geng, Y., & Troisi, A. (2020) · Chemistry of Materials · doi:10.1021/acs.chemmater.0c02325 · Cited by 102
Badapple: promiscuity patterns from noisy evidence
Yang, J. J., Ursu, O., Lipinski, C. A., Sklar, L. A., Oprea, T. I., & Bologa, C. G. (2016) · Journal of Cheminformatics · doi:10.1186/s13321-016-0137-3 · Cited by 103
Self-citationCommunity Health Care: Therapeutic Opportunities in the Human Microbiome
Sonnenburg, J. L., & Fischbach, M. A. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001626 · Cited by 102
Link-INVENT: Generative Linker Design with Reinforcement Learning
Guo, J., Knuth, F., Margreitter, C., Janet, J. P., Papadopoulos, K., Engkvist, O., & Patronov, A. (2022) · doi:10.26434/chemrxiv-2022-qkx9f · Cited by 101
An automated PLS search for biologically relevant QSAR descriptors
Olah, M., Bologa, C., & Oprea, T. I. (2004) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-004-4060-8 · Cited by 91
Nogara, P. A., Saraiva, R. D. A., Caeran Bueno, D., Lissner, L. J., Lenz Dalla Corte, C., Braga, M. M., Rosemberg, D. B., & Rocha, J. B. T. (2015) · BioMed Research International · doi:10.1155/2015/870389 · Cited by 89
Discovering small-molecule senolytics with deep neural networks
Wong, F., Omori, S., Donghia, N. M., Zheng, E. J., & Collins, J. J. (2023) · Nature Aging · doi:10.1038/s43587-023-00415-z · Cited by 82
Pharmacokinetically Based Mapping Device for Chemical Space Navigation
Oprea, T. I., Zamora, I., & Ungell, A.-L. (2002) · Journal of Combinatorial Chemistry · doi:10.1021/cc010093w · Cited by 77
Scott, L. E., Telpoukhovskaia, M., Rodríguez-Rodríguez, C., Merkel, M., Bowen, M. L., Page, B. D. G., Green, D. E., Storr, T., Thomas, F., Allen, D. D., et al. (2011) · Chem. Sci. · doi:10.1039/c0sc00544d · Cited by 68
Dolles, D., Hoffmann, M., Gunesch, S., Marinelli, O., Möller, J., Santoni, G., Chatonnet, A., Lohse, M. J., Wittmann, H.-J., Strasser, A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01760 · Cited by 67
Puentes-Díaz, N., Chaparro, D., Morales-Morales, D., Flores-Gaspar, A., & Alí-Torres, J. (2023) · ACS Omega · doi:10.1021/acsomega.2c06939 · Cited by 67
Plucking the high hanging fruit: A systematic approach for targeting protein–protein interactions
Raj, M., Bullock, B. N., & Arora, P. S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.11.023 · Cited by 66
The Design of Orally Active Iron Chelators
HIDER, R. C., & ZHOU, T. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.017 · Cited by 64
Oftedal, L., Selheim, F., Wahlsten, M., Sivonen, K., Døskeland, S. O., & Herfindal, L. (2010) · Marine Drugs · doi:10.3390/md8102659 · Cited by 62
A structural analysis of the FDA green book-approved veterinary drugs and roles in human medicine
Scott, K. A., Qureshi, M. H., Cox, P. B., Marshall, C. M., Bellaire, B. C., Wilcox, M., Stuart, B. A. R., & Njardarson, J. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01502 · Cited by 56
The effect of mangiferin on skin: Penetration, permeation and inhibition of ECM enzymes
Ochocka, R., Hering, A., Stefanowicz–Hajduk, J., Cal, K., & Barańska, H. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181542 · Cited by 56
Recent developments on 3-hydroxy-4-pyridinones with respect to their clinical applications
Santos, M. A. (2008) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2008.01.033 · Cited by 54
Trapotsi, M.-A., Mouchet, E., Williams, G., Monteverde, T., Juhani, K., Turkki, R., Miljković, F., Martinsson, A., Mervin, L., Pryde, K. R., et al. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00076 · Cited by 51
Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
Zagórska, A., & Jaromin, A. (2020) · Molecules · doi:10.3390/molecules25153337 · Cited by 51
IFITM proteins assist cellular uptake of diverse linked chemotypes
Lou, K., Wassarman, D. R., Yang, T., Paung, Y., Zhang, Z., O’Loughlin, T. A., Moore, M. K., Egan, R. K., Greninger, P., Benes, C. H., et al. (2022) · Science · doi:10.1126/science.abl5829 · Cited by 42
Iwanaga, K., Kushibiki, T., Miyazaki, M., & Kakemi, M. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.508 · Cited by 38
Othman, A., Sayed, A. M., Amen, Y., & Shimizu, K. (2022) · RSC Advances · doi:10.1039/d2ra02275c · Cited by 32
Akhtar, A., Hussain, W., & Rasool, N. (2019) · Universitas Scientiarum · doi:10.11144/javeriana.sc24-3.artf · Cited by 27
The chelation targeting metal–Aβ40 aggregates may lead to formation of Aβ40 oligomers
Zhang, Y., Chen, L.-Y., Yin, W.-X., Yin, J., Zhang, S.-B., & Liu, C.-L. (2011) · Dalton Transactions · doi:10.1039/c1dt00020a · Cited by 26
The therapeutic antibody profiler for computational developability assessment
Raybould, M. I. J., & Deane, C. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1450-1_5 · Cited by 25
Nadh, A. G., Revikumar, A., Sudhakaran, P. R., & Nair, A. S. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105422 · Cited by 22
Focused Libraries for Epigenetic Drug Discovery: The Importance of Isosteres: Miniperspective
Green, A. I., & Burslem, G. M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00592 · Cited by 21
Sako, M., Yasuo, N., & Sekijima, M. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01385 · Cited by 21
Paterson, S., Alonso-Pintre, L., Morato-López, E., González de la Fuente, S., Gómez-Cortés, P., & Hernández-Ledesma, B. (2025) · Foods · doi:10.3390/foods14020252 · Cited by 20
Avram, S., Curpan, R., Halip, L., Bora, A., & Oprea, T. I. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00826 · Cited by 18
Metadata
- Authors
- Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 1997-01
- Volume
- 23
- Issue
- 1-3
- Pages
- 3-25
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4248107770
- Cited by
- 11,385
- References
- 0
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.